SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-21-007319
Filing Date
2021-03-26
Accepted
2021-03-26 16:30:43
Documents
8
Period of Report
2021-05-21

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A nby20210322_pre14a.htm PRE 14A 531200
2 bulletimg.jpg GRAPHIC 808
3 card1.jpg GRAPHIC 182649
4 card2.jpg GRAPHIC 128295
5 imgc.jpg GRAPHIC 38774
6 n1.jpg GRAPHIC 9515
7 n2.jpg GRAPHIC 9997
8 sig.jpg GRAPHIC 3926
  Complete submission text file 0001437749-21-007319.txt   1047924
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33678 | Film No.: 21777871
SIC: 2834 Pharmaceutical Preparations